TECHNOLAS PERFECT VISION, INC.

What TECHNOLAS PERFECT VISION, INC. does

Technolas Perfect Vision GmbH is a Munich-based ophthalmic medical device company founded in 1985 that designs and supplies laser systems and diagnostic imaging devices for refractive, cataract, and therapeutic eye surgery. Its commercial portfolio comprises two proprietary laser platforms developed by its German engineering team — the TECHNOLAS TENEO 317 Model 2 excimer laser and the VICTUS femtosecond laser platform — complemented by two diagnostic imaging systems, the ANTERION multimodal imaging platform (legal manufacturer Heidelberg Engineering) and the Sirius+ topographer (legal manufacturer CSO), both of which integrate with the TENEO laser for refractive treatment planning.

The company operates as a wholly-owned subsidiary of Bausch + Lomb within the Bausch Health Companies group, and distributes its products through Bausch + Lomb's global enterprise sales and distribution network covering more than 40 countries. Its customer base consists of healthcare providers — primarily eye surgery clinics, hospitals, and refractive surgery centers — that purchase capital equipment via direct, quote-based procurement rather than recurring software or service contracts. The business model is therefore classic medical-device hardware sales, with revenue tied to placement of high-priced laser and imaging systems rather than subscription or per-procedure fees.

Following its reacquisition by Bausch + Lomb in 2013, the entity now functions primarily as the refractive-product arm of Bausch + Lomb Surgical, with limited independent go-to-market activity and no disclosed standalone funding, leadership, or independent revenue line. Day-to-day commercial reach, regulatory affairs, and country-level operations are executed under the Bausch + Lomb Surgical brand.

Name

TECHNOLAS PERFECT VISION, INC.

Legal name

Technolas Perfect Vision GmbH

Website

https://technolas.com

Company type

Private

Founded year

1985

Operating status

Operating

Headcount range

1–10 employees

Short description

Technolas Perfect Vision GmbH is a Munich-based ophthalmic medical device subsidiary of Bausch + Lomb that designs refractive and cataract laser systems (TECHNOLAS TENEO, VICTUS) and integrated diagnostic imaging devices sold to eye surgery clinics and hospitals globally.

Ownership category

akta.pro rank

Product category

Ophthalmic Medical Devices

NAICS

Surgical and Medical Instrument Manufacturing (339112), Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)

SIC

Surgical & Medical Instruments & Apparatus (3841), Electromedical & Electrotherapeutic Apparatus (3845), Optical Instruments & Lenses (3827)

akta.pro primary industry

Refractive Surgery Systems (Excimer/Femtosecond Lasers, Phakic IOL Systems, Wavefront/Guidance) (HLAHAJAG)

akta.pro secondary industries

Cataract Surgery Systems & IOLs (Phaco Systems, IOLs, Intraoperative Aberrometry, Viscoelastics) (HLAHAJAH), Cornea, External Disease & Refractive Surgery (LASIK/PRK) (HLAKAKAF)

Keywords

• Ophthalmic laser systems
• Refractive surgery devices
• Cataract surgery equipment
• Diagnostic imaging platforms
• Femtosecond laser platforms

Headquarters

HQ city

St Louis, Missouri

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Operations, Supply Chain, Personnel, Marketing or Sales, Infrastructure

Revenue model

1. Medical Device Sales: Sale of high-end ophthalmic laser systems (excimer and femtosecond lasers) and diagnostic imaging devices to eye surgery clinics, hospitals, and refractive surgery centers. Capital equipment sales model typical of medical device industry targeting healthcare facilities.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

Core offering

Technolas Perfect Vision GmbH designs, manufactures, and sells high-end ophthalmic laser systems and diagnostic imaging devices for refractive, cataract, and therapeutic eye surgery. Its portfolio includes the proprietary TECHNOLAS TENEO™ 317 Model 2 excimer laser, the VICTUS™ femtosecond laser platform, and complementary anterior-segment diagnostic imaging devices (ANTERION® and Sirius+). These capital equipment systems are sold to eye surgery clinics, hospitals, and refractive surgery centers globally through Bausch + Lomb's distribution network.

Product overview

Technolas Perfect Vision GmbH offers an integrated refractive surgery portfolio consisting of two proprietary laser platforms and two diagnostic imaging devices. The core offerings include the TECHNOLAS TENEO™ 317 Model 2 Excimer Laser and VICTUS™ Femtosecond Laser Platform, both developed by the company's German engineering team in Munich. These are complemented by two diagnostic imaging platforms—ANTERION® Multimodal Imaging Platform (from Heidelberg Engineering) and Sirius+ (from CSO)—which seamlessly connect to the TENEO laser to support refractive treatments. The portfolio covers refractive, cataract, and therapeutic eye surgery applications.

Differentiator

Problem solved

Functional benefit

Brands

• TECHNOLAS TENEO™ 317 Model 2: Excimer laser system for refractive surgery, designed by German engineering team at Technolas Perfect Vision GmbH
• VICTUS™ Femtosecond Laser Platform
• ANTERION® Multimodal Imaging Platform
• Sirius+

Products and services

• TECHNOLAS TENEO™ 317 Model 2 Excimer Laser

Quantifiable outcome

• Seamless connectivity between TENEO laser and diagnostic systems (ANTERION, Sirius+) for optimized treatment planning

Segments1 record

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

One partnership is on record.

• Bausch + LombcoreStrategic or Co-development PartnerTechnolas Perfect Vision is a wholly-owned subsidiary of Bausch + Lomb, which is part of Bausch Health Companies. Acquired by Bausch + Lomb in 1998, reacquired in 2013. The company operates as 'A Bausch + Lomb Company' and utilizes the parent company's global distribution network and brand presence.

Scale indicators3 records

Recent moves3 records

Expansion highlights2 records

Broad incumbents

• Bausch + Lomb: Bausch + Lomb is Technolas' parent company and a broad incumbent in ophthalmology — it encompasses surgical IOLs, pharmaceuticals, contact lenses, and consumer eye care well beyond refractive lasers, providing the global commercial infrastructure through which Technolas products are sold.
• Lumenis (a Boston Scientific company): Lumenis, now part of Boston Scientific, is a broad incumbent in ophthalmic lasers (including selective laser trabeculoplasty and YAG laser systems) that overlaps with Technolas' therapeutic indication use case and competes for ophthalmic surgical laser capital budgets in clinics and hospitals.

Direct peers

• NIDEK: NIDEK is a Japanese ophthalmic equipment manufacturer that directly competes with Technolas in refractive excimer lasers (EC-5000, Quest) and diagnostic devices (OPD-Scan, OPDIII), serving refractive surgery clinics globally with comparable capital equipment offerings.
• Carl Zeiss Meditec: Zeiss Meditec is a direct competitor in refractive and cataract surgery with its VisuMax femtosecond laser (the pioneering platform for SMILE small-incision lenticule extraction) and MEL excimer laser, competing for the same installed-base refresh and new-clinic capital purchases as Technolas' VICTUS and TENEO platforms.
• Ziemer Ophthalmic Systems: Ziemer is a Swiss specialist in low-energy femtosecond lasers for cataract and refractive surgery (Femto LDV Z8), directly competing with Technolas' VICTUS platform in the ophthalmic femtosecond segment with a differentiated low-pulse-energy technology approach.
• Alcon: Alcon is the global leader in ophthalmic surgical devices and directly competes with Technolas across refractive excimer (WaveLight EX500) and femtosecond cataract platforms (LenSx, Centurion), serving the same eye surgery clinics and refractive centers via a comparable direct enterprise sales motion.
• Nova Eye Medical (formerly Ellex Medical Lasers): Nova Eye Medical, through its legacy Ellex business, manufactures and sells ophthalmic laser systems for cataract and glaucoma treatment (e.g., Tango, Solo), directly competing with Technolas in the ophthalmic laser device category and serving similar surgical ophthalmology customers.
• Johnson & Johnson Vision: J&J Vision competes head-to-head with Technolas in refractive surgery via its iDESIGN Refractive Studio (wavefront-guided) and iFS Advanced Femtosecond Laser, targeting the same ophthalmologist and LASIK clinic customers with an integrated laser + diagnostics ecosystem analogous to Technolas' TENEO + ANTERION/Sirius+ stack.

Emerging players

• CSO (Costruzione Strumenti Oftalmici): CSO is the Italian manufacturer of the Sirius+ corneal topography/tomography device distributed by Technolas. It is a relevant peer because it is the upstream OEM for one of Technolas' core diagnostic products and independently sells competing diagnostic devices into the same refractive surgery market.
• Heidelberg Engineering: Heidelberg Engineering is the legal manufacturer of the ANTERION Multimodal Imaging Platform that Technolas distributes — a key technology partner with overlapping expertise in anterior segment swept-source OCT imaging and complementary diagnostic products sold into the same ophthalmology clinical base.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• Xtwitter.com/bauschsurgical
• LinkedInlinkedin.com/company/technolas-perfect-vision-inc.

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about TECHNOLAS PERFECT VISION, INC.